OS Therapies Inc
OSTX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001795091
No open-market purchases or sales by OS Therapies Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $5.50M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by OS Therapies Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for OS Therapies Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Petit Robert | See Remarks | – | Feb 13, 2026 | 2 |
| Jarry Olivier Roger | Director | – | Feb 13, 2026 | 2 |
| Ciccio John | Director | 435,835Indirect | Feb 13, 2026 | 2 |
| Search Theodore F. | Director | 435,835Indirect | Feb 13, 2026 | 2 |
| Romness Paul A. | President and CEO | 2,473,000 | Feb 13, 2026 | 2 |
| Acevedo Christopher P. | Chief Financial Officer | – | Feb 13, 2026 | 2 |
| McKean-Dieser Avril Suzette | Director | – | Feb 13, 2026 | 2 |
| Galzahr Karim | Director | – | Feb 13, 2026 | 2 |
| Auerbach Shalom | Other: Former 10% Owner | 2,664,199Indirect | May 9, 2025 | 0 |
| Einodmil LLC | Other: Former 10% Owner | 2,664,199Indirect | May 9, 2025 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 (view filing)9:30 PM ET | May 7 | 2 days | Auerbach Shalom and 1 other10% Owner | SSaleCommon Stock, par value $0.001 per share | −82.0K | $2.00 | −$163.9K | −3.0%2.66M after | |
| Apr 11, 2025 (view filing)9:45 PM ET | Apr 9-10 | 2 days | Auerbach Shalom and 1 other10% Owner | SSaleCommon Stock, par value $0.001 per share | −60.0K | $1.36 | −$81.6K | −2.1%2.75M after | 2 lots |
| Feb 18, 2025 (view filing)9:00 PM ET | Feb 14 | 4 days | Auerbach Shalom and 1 other10% Owner | SSaleCommon Stock, par value $0.001 per share | −100.0K | $2.84 | −$284.3K | −4.0%2.43M after | |
| Jan 17, 2025 (view filing)7:00 PM ET | Jan 15 | 2 days | Auerbach Shalom and 1 other10% Owner | SSaleCommon Stock, par value $0.001 per share | −16.7K | $6.74 | −$112.6K | −0.7%2.53M after |